We read with great interest the study by Fitzpatrick et al,1 showing how, in preschool children with persistent asthma, the type 2 inflammation biomarkers (ie, aeroallergen sensitization and/or increased blood eosinophilic counts) are strong predictors of a positive therapeutic response to daily inhaled corticosteroid treatment. To our knowledge, Fitzpatrick et al's study is the first to extrapolate and clearly identify a particular phenotype of persistent eosinophilic asthma, without pneumoallergen sensitization.
http://ift.tt/2u9esxz
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου